Key result
TPT1 silencing reverses cardiomyocyte apoptosis in preclinical sepsis-induced cardiomyopathy.
Why the study?
Sepsis-induced cardiomyopathy is a critical factor exacerbating patient mortality, but its underlying genetic mechanisms require further research.
Does silencing TPT1 protect against lipopolysaccharide-induced apoptosis and cell cycle arrest in murine myocardial cells, and are Tpt1, Mmp9, and Fth1 overexpressed in preclinical models of sepsis-induced cardiomyopathy?
Does silencing TPT1 protect against lipopolysaccharide-induced apoptosis and cell cycle arrest in murine myocardial cells, and are Tpt1, Mmp9, and Fth1 overexpressed in preclinical models of sepsis-induced cardiomyopathy?
This preclinical study identifies Tpt1, Mmp9, and Fth1 as potential biomarkers upregulated in sepsis-induced cardiomyopathy and demonstrates that silencing TPT1 mitigates LPS-induced cardiomyocyte apoptosis and cell cycle arrest in vitro.
Hypothesis-generating for TPT1-targeted therapy in sepsis cardiomyopathy; leaves open translation to human disease.
Introduction Sepsis is a life-threatening disease that damages multiple organs and induced by the host’s dysregulated response to infection with high morbidity and mortality. Heart remains one of the most vulnerable targets of sepsis-induced organ damage, and sepsis-induced cardiomyopathy (SIC) is an important factor that exacerbates the death of patients. However, the underlying genetic mechanism of SIC disease needs further research. Methods The transcriptomic dataset, GSE171564 , was downloaded from NCBI for further analysis. Gene expression matrices for the sample group were obtained by quartile standardization and log 2 logarithm conversion prior to analysis. The time series, protein-protein interaction (PPI) network, and functional enrichment analysis via Gene Ontology and KEGG Pathway Databases were used to identify key gene clusters and their potential interactions. Predicted miRNA-mRNA relationships from multiple databases facilitated the construction of a TF-miRNA-mRNA regulatory network. In vivo experiments, along with qPCR and western blot assays, provided experimental validation. Results The transcriptome data analysis between SIC and healthy samples revealed 221 down-regulated, and 342 up-regulated expressed genes across two distinct clusters. Among these, Tpt1, Mmp9 and Fth1 were of particular significance. Functional analysis revealed their role in several biological processes and pathways, subsequently, in vivo experiments confirmed their overexpression in SIC samples. Notably, we found TPT1 play a pivotal role in the progression of SIC, and silencing TPT1 showed a protective effect against LPS-induced SIC. Conclusion In our study, we demonstrated that Tpt1, Mmp9 and Fth1 have great potential to be biomarker of SIC. These findings will facilitated to understand the occurrence and development mechanism of SIC.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2023) studied Sepsis-induced cardiomyopathy (SIC) (n=12). Cecal ligation and puncture (in vivo) / LPS treatment and TPT1 siRNA silencing (in vitro) vs. Sham laparotomy surgery (in vivo) / Control medium or negative control siRNA (in vitro) was evaluated on Differential gene/protein expression of hub genes (Tpt1, Mmp9, Fth1) and cardiomyocyte apoptosis/cell cycle arrest (p=<0.01). Integrated bioinformatics and preclinical experiments identified 342 up-regulated and 221 down-regulated genes in sepsis-induced cardiomyopathy, with TPT1 silencing reversing LPS-induced apoptosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: